Rami Katkhuda
Stock Analyst at LifeSci Capital
(4.89)
# 503
Out of 5,116 analysts
345
Total ratings
52.9%
Success rate
26.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rami Katkhuda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRON Disc Medicine | Reiterated: Buy | $100 → $130 | $78.91 | +64.74% | 42 | Oct 19, 2026 | |
| VRDN Viridian Therapeutics | Reiterated: Buy | $35 | $28.49 | +22.85% | 49 | Oct 2, 2026 | |
| JBIO Jade Biosciences | Reiterated: Buy | $42 | $15.07 | +178.70% | 7 | Sep 30, 2026 | |
| MLTX MoonLake Immunotherapeutics | Reiterated: Buy | $33 | $11.53 | +186.21% | 43 | Sep 30, 2026 | |
| DNTH Dianthus Therapeutics | Reiterated: Buy | $125 | $86.03 | +45.30% | 25 | Sep 29, 2026 | |
| IVA Inventiva | Reiterated: Buy | $14 | $3.80 | +268.42% | 13 | Sep 28, 2026 | |
| ABSI Absci | Reiterated: Buy | $16 | $10.17 | +57.33% | 2 | Sep 24, 2026 | |
| ELDN Eledon Pharmaceuticals | Reiterated: Buy | $8 | $2.61 | +207.10% | 44 | Sep 22, 2026 | |
| MAZE Maze Therapeutics | Reiterated: Buy | $57 | $34.19 | +66.72% | 8 | Sep 22, 2026 | |
| VERA Vera Therapeutics | Reiterated: Buy | $90 | $29.79 | +202.17% | 40 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $29.50 | +49.15% | 17 | Aug 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 | $15.60 | +258.97% | 24 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $12.44 | +221.54% | 2 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $54 | $15.33 | +252.25% | 25 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $170 | $138.78 | +22.50% | 4 | Aug 11, 2026 |
Disc Medicine
Oct 19, 2026
Reiterated: Buy
Price Target: $100 → $130
Current: $78.91
Upside: +64.74%
Viridian Therapeutics
Oct 2, 2026
Reiterated: Buy
Price Target: $35
Current: $28.49
Upside: +22.85%
Jade Biosciences
Sep 30, 2026
Reiterated: Buy
Price Target: $42
Current: $15.07
Upside: +178.70%
MoonLake Immunotherapeutics
Sep 30, 2026
Reiterated: Buy
Price Target: $33
Current: $11.53
Upside: +186.21%
Dianthus Therapeutics
Sep 29, 2026
Reiterated: Buy
Price Target: $125
Current: $86.03
Upside: +45.30%
Inventiva
Sep 28, 2026
Reiterated: Buy
Price Target: $14
Current: $3.80
Upside: +268.42%
Absci
Sep 24, 2026
Reiterated: Buy
Price Target: $16
Current: $10.17
Upside: +57.33%
Eledon Pharmaceuticals
Sep 22, 2026
Reiterated: Buy
Price Target: $8
Current: $2.61
Upside: +207.10%
Maze Therapeutics
Sep 22, 2026
Reiterated: Buy
Price Target: $57
Current: $34.19
Upside: +66.72%
Vera Therapeutics
Sep 15, 2026
Reiterated: Buy
Price Target: $90
Current: $29.79
Upside: +202.17%
Aug 22, 2026
Reiterated: Buy
Price Target: $44
Current: $29.50
Upside: +49.15%
Aug 13, 2026
Reiterated: Buy
Price Target: $56
Current: $15.60
Upside: +258.97%
Aug 12, 2026
Reiterated: Buy
Price Target: $40
Current: $12.44
Upside: +221.54%
Aug 12, 2026
Reiterated: Buy
Price Target: $54
Current: $15.33
Upside: +252.25%
Aug 11, 2026
Reiterated: Buy
Price Target: $170
Current: $138.78
Upside: +22.50%